Robert S. Lowrey serves as Executive at BIOCRYST PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Robert S. Lowrey has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 1, 2018 involved receiving (via award) 250,000 shares valued at $0.
Robert S. Lowrey currently holds 1,000,000 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert S. Lowrey has been a net neutral trader of BCRX stock. They have purchased $0 and sold $0 worth of shares.
Robert S. Lowrey's most recent insider trade was on Aug 1, 2018, when they sold 250,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 15, 2012 | BCRX | $14.0K | Payment | 2,686 | $5.23 | Discretionary |
| Mar 15, 2012 | BCRX | $0 | Award | 7,327 | $N/A | Discretionary |
| Mar 1, 2012 | BCRX | $0 | Award | 5,125 | $N/A | Discretionary |